Glenmark Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GLENMARK PHARMS, and what generic and branded alternatives to GLENMARK PHARMS drugs are available?
GLENMARK PHARMS has one hundred and eighty-six approved drugs.
There are eight tentative approvals on GLENMARK PHARMS drugs.
Drugs and US Patents for Glenmark Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glenmark Pharms Ltd | ICATIBANT ACETATE | icatibant acetate | INJECTABLE;SUBCUTANEOUS | 213222-001 | May 21, 2021 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Glenmark Pharms Ltd | ATOMOXETINE HYDROCHLORIDE | atomoxetine hydrochloride | CAPSULE;ORAL | 079019-002 | May 30, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glenmark Pharms Ltd | NAPROXEN | naproxen | TABLET;ORAL | 078250-001 | Mar 28, 2007 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for GLENMARK PHARMS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.